Previous 10 | Next 10 |
Becton, Dickinson (NYSE:BDX): FQ4 Non-GAAP EPS of $2.59 beats by $0.14; GAAP EPS of $0.84 misses by $0.74. Revenue of $5.14B (+7.5% Y/Y) beats by $230M. Press Release BD issues fiscal 2022 guidance of $19.3 to $19.5 billion in revenues and $12.30 to $12.50 adjusted diluted EPS; includes base ...
BD Announces Fourth Fiscal Quarter And Full Year 2021 Results; Issues Fiscal Year 2022 Guidance - Fourth fiscal quarter revenues of $5.1 billion grew 7.3% on a reported basis or 5.9% on a currency-neutral basis. - Fiscal 2021 full-year revenues of $20.2 billion grew 18.3% on...
BD Board Increases Dividend for 50th Consecutive Year, Authorizes 10 Million Additional Share Repurchases PR Newswire FRANKLIN LAKES, N.J. , Nov. 4, 2021 /PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has...
Becton, Dickinson (NYSE:BDX) is scheduled to announce FQ4 earnings results on Thursday, November 4th, before market open. The consensus EPS Estimate is $2.45 (-12.2% Y/Y) and the consensus Revenue Estimate is $4.91B (+2.7% Y/Y). Becton, Dickinson reported financial results for fisca...
Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This report optimizes tradi...
Becton, Dickinson and Co (NYSE:BDX) announces collaboration with U.S. government for the development of COVID-19 combination diagnostic tests. As part of the collaboration, Biomedical Advanced Research and Development Authority (BARDA) will award Becton an initial $24.7M, with optio...
BD Collaborates with U.S. Government on Development of COVID-19 Combination Diagnostic Tests BARDA to Invest $24.7 Million for BD to Develop New Tests for Core Labs, Hospitals and Point-of-Care Locations PR Newswire FRANKLIN LAKES, N.J. , Oct. 28, 2021 /PRNew...
William von Mueffling's 13F portfolio value decreased this quarter from $14.85B to $14.67B. Cantillon increased Brunswick Corp while dropping Nielsen Holdings. The portfolio continues to be very concentrated with the top five positions accounting for ~26% of the 13F portfolio. ...
NOBL is having an excellent return in October thus far, almost fully recouping all of September's losses. I present 3 strategies that theoretically can beat the dividend aristocrat index in the long term. All 3 strategies are underperforming NOBL in October thus far, however, two ...
BD to Host Investor Day on November 12 Event will provide strategic update, with focus on company's innovation and growth agendas PR Newswire FRANKLIN LAKES, N.J. , Oct. 26, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading gl...
News, Short Squeeze, Breakout and More Instantly...
Becton Dickinson and Company Company Name:
BDX Stock Symbol:
NYSE Market:
Becton Dickinson and Company Website:
BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases PR Newswire Collaboration on Flow Cytometry-Based Companion Diagnostics to Advance Personalized Health Care FRANKLIN LAKES, N.J. and SECAUCUS, N.J. , July 25, 20...
2024-07-11 12:00:00 ET July 11, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the second of a two-part series looking at recent news and developments in the blood infections treatment market, featuring Citius Pharmaceuticals, Inc. ( Nasdaq:C...
BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials PR Newswire Company Committed to Support Global Health and Customers BD Taking all Available Measures to Mitigate Supplier Issue FRANKLIN LAKES, N.J. , July 10 , 2024...